Atrin Pharmaceuticals
http://atrinpharma.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Atrin Pharmaceuticals
Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m
Bookmark
-
News
Already owner of about 60% of the troubled antibiotic firm, Innoviva agrees to pay $2.20 per share for all outstanding stock in Entasis. Roche, KaliVir partner on oncolytic virus therapies.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Aprea Therapeutics, Inc.
Advertisement
Advertisement